Frank Theil

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2021
Publications (10 Years): 4

Top Topics

Raman Spectroscopy

Risk Assessment

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Bo Liu, Frank Theil, Kristin Voges, David Gessner, Yanxia Li, Holger van Lishaut
Crystallization Risk Assessment of Amorphous Solid Dispersions by Physical Shelf-Life Modeling: A Practical Approach. Molecular pharmaceutics 18 (6) (2021)
Frank Theil, Johanna Milsmann, Sankaran Anantharaman, Holger van Lishaut
Manufacturing Amorphous Solid Dispersions with a Tailored Amount of Crystallized API for Biopharmaceutical Testing. Molecular pharmaceutics 15 (5) (2018)
Frank Theil, Johanna Milsmann, Samuel O Kyeremateng, Sankaran Anantharaman, Jörg Rosenberg, Holger van Lishaut
Extraordinary Long-Term-Stability in Kinetically Stabilized Amorphous Solid Dispersions of Fenofibrate. Molecular pharmaceutics 14 (12) (2017)
Frank Theil, Sankaran Anantharaman, Samuel O Kyeremateng, Holger van Lishaut, Sebastian H Dreis-Kühne, Jörg Rosenberg, Markus Mägerlein, Gerd H Woehrle
Frozen in Time: Kinetically Stabilized Amorphous Solid Dispersions of Nifedipine Stable after a Quarter Century of Storage. Molecular pharmaceutics 14 (1) (2016)